- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 253/075 - Two hetero atoms, in positions 3 and 5
Patent holdings for IPC class C07D 253/075
Total number of patents in this class: 107
10-year publication summary
|
7
|
8
|
5
|
5
|
7
|
10
|
11
|
3
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nektar Therapeutics | 438 |
9 |
| HMI Medical Innovations, LLC | 16 |
8 |
| United Kingdom Research and Innovation | 364 |
5 |
| Bayer Cropscience AG | 2057 |
4 |
| Inflectis Bioscience | 15 |
4 |
| Addex Pharma SA | 62 |
3 |
| University of Greenwich | 71 |
3 |
| The Hebrew University of Jerusalem | 48 |
2 |
| Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences | 3 |
2 |
| Shionogi & Co., Ltd. | 867 |
2 |
| Stahl International B.V. | 286 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 589 |
2 |
| University of Cincinnati | 860 |
2 |
| The University of North Carolina at Chapel Hill | 2024 |
2 |
| The University of Texas System | 21 |
2 |
| UPL Limited | 578 |
2 |
| Shanghai Aucta Pharmaceuticals Co. Ltd. | 13 |
2 |
| Eccogene Inc. | 8 |
2 |
| Genentech, Inc. | 3968 |
1 |
| Merck Sharp & Dohme Corp. | 2201 |
1 |
| Other owners | 47 |